Daniela Galliano, M.D., Ph.D.

Director of IVI Rome

IVI Rome

Daniela Galliano, M.D., Ph.D.

Biografía

Dr. Daniela Galliano is the Director of IVI Rome. She obtained her medical degree from the University of Torino in Italy, and completed her residency in Obstetrics and Gynecology at the Virgen de las Nieves University Hospital, Granada, Spain, where she also obtained her Ph.D. with cum laude, investigating genetic polymorphisms that influences fertility.

She joined the Instituto Valenciano de Infertilidad (IVI) in 2009, and participated in research projects in endocrinology of reproduction and Iinfertility at Weill Cornell Medical College, New York, NY (USA), and Reproductive Medicine Associates (RMA), , Basking Ridge, NJ (USA). Her research interests also include the role of uterine pathologies in infertility and alternative treatments in older reproductive-age women. She has been an invited speaker in multiple national and international scientific meetings.

Read more

Formación

M.D. Turin, Italy University School of Medicine (2001)
Post-doctoral Fellow at the Institute for Cancer Research and Treatment Italy (2007)
Accreditation for Level III of Ultrasound, Fetal Medicine Unit Virgen de las Nieves University Hospital, Granada (2008)
Ph.D. Granada University School of Medicine (2009)
Residency in Obstetrics and Gynecology Hospital Universitario Virgen de las Nieves, Granada, Spain (2009)

Honores y reconocimientos

Member Sociedad Española de Ginecología y Obstetricia (SEGO)
Member Sociedad Española de Fertilidad (SEF)
Member International Society of Ginecological Endocrinology (ISGE)

Publicaciones


  • Protocols to induce ovulation and “progesterone block” experiments.
    Galliano D.
    Fertil Steril; 106 (3): 558, 2016.

  • Hysteroscopy before IVF: can it improve outcomes?
    Pellicer A, Galliano D.
    Lancet; 387 (10038): 2578-2579, 2016.

  • A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept.
    Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, Fischer R, Galliano D, Polyzos NP, Sunkara SK, Ubaldi FM, Humaidan P.
    Fertil Steril; 105 (6): 1452-1453, 2016.

  • The challenge of embryonic mosaicism in preimplantation genetic screening.
    Scott RT, Galliano D.
    Fertil Steril; 105 (5): 1150-1152, 2016.

  • Ovarian stimulation, insemination, and contraception.
    Galliano D.
    Fertil Steril; 105 (3): 607, 2016.

  • Optimal uterine anatomy and physiology necessary for normal implantation and placentation.
    De Ziegler D, Pirtea P, Galliano D, Cicinelli E, Meldrum D.
    Fertil Steril; 105 (4): 844-854, 2016.

  • Blastocyst development in single medium with or without renewal on day 3: a prospective cohort study on sibling donor oocytes in a time-lapse incubator.
    Costa-Borges N, Bellés M, Meseguer M, Galliano D, Ballesteros A, Calderón G.
    Fertil Steril; 105 (3): 707-713, 2016.

  • The future of reproductive medicine centers.
    Pellicer A, Galliano D.
    Fertil Steril; 105 (1): 30-31, 2016.


  • Difference in birth weight of consecutive sibling singletons is not found in oocyte donation when comparing fresh versus frozen embryo replacements.
    Galliano D, Garrido N, Serra-Serra V, Pellicer A.
    Fertil Steril; 104 (6): 1411-1418, 2015.

  • Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization.
    Bellver J, De los Santos MJ, Alamá P, Castelló D, Privitera L, Galliano D, Labarta E, Vidal C, Pellicer A, Domínguez F.
    Fertil Steril; 103 (6): 1407-1415, 2015.

  • Spanish consensus on premature menopause.
    Mendoza N, Juliá MD, Galliano D, Coronado P, Díaz P, Fontes J, Gallo JL, Garcia A, Guinot M, Munnamy M, Roca B, Sosa M, Tomás J, LLaneza P, Sánchez-Borrego R. Maturitas; 80 (2): 220-5, 2015.

  • Ulipristal acetate in uterine fibroids.
    Galliano D.
    Fertil Steril; 103 (2): 359-60, 2015.

  • ART and uterine pathology: how relevant is the maternal side for implantation?
    Galliano D, Bellver J, Díaz-García C, Simón C, Pellicer A.
    Hum Reprod Update; 21 (1): 13-38, 2015.

  • Successful pregnancy after treatment with ulipristal acetate for uterine fibroids.
    Monleón J, Martínez-Varea A, Galliano D, Pellicer A.
    Case Rep Obstet Gynecol; 2014: 314587, 2014

  • MicroRNA and implantation.
    Galliano D, Pellicer A.
    Fertil Steril; 101 (6): 1531-1544, 2014.

  • Introduction: MicroRNAs in human reproduction: small molecules with crucial regulatory roles.
    Imbar T, Galliano D, Pellicer A, Laufer N.
    Fertil Steril; 101 (6): 1514-5, 2014.

  • Menoguía sobre menopausia precoz.
    Díaz B, Fontes J, Galliano D, Gallo L, García A, Coto P, Munnamy M, Sosa M, Roca B, Massaguer J.
    AEEM. 1-36, 2014. (Guide)

  • Female obesity: short- and long-term consequences on the offspring.
    Galliano D, Bellver J.
    Gynecol Endocrinol; 29 (7): 626-631, 2013.

  • Lowering the age at menarche and risk of early menarche in a population of Spanish postmenopausal women during the past two decades.
    Mendoza N, Galliano D, Salamanca A, Castro JE, Mozas J, Sánchez-Borrego R, Quereda F, Vázquez F, Martínez-Astorquiza T.
    Menopause Int; 16 (3): 111-4, 2010.

  • Multigenic combination of estrogen-related genes is associated with age at natural menopause in a Spanish population.
    Mendoza N, Sánchez-Borrego R, Galliano D, Salamanca A, Mozas J, Quereda F, Vázquez F, Martínez-Astorquiza T, Moron F.
    Menopause Int; 15 (4): 150-6, 2009.

Read more

Presentations

Read more
Cerrar menú